المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/dataset/Table_1_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_docx/19094207

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s004

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/dataset/Table_4_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_docx/19094216

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s007

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/figure/Image_2_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_tif/19094201

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s002

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/figure/Image_1_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_tif/19094198

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s001

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/dataset/Table_3_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_docx/19094213

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s006

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/dataset/Table_5_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_docx/19094219

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s008

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/figure/Image_3_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_tif/19094204

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s003

المؤلفون: Marc A. Schneider (10160787), Adriana Rozy (12021584), Sabine Wrenger (12021587), Petros Christopoulos (10429900), Thomas Muley (87877), Michael Thomas (279566), Michael Meister (120830), Tobias Welte (87188), Joanna Chorostowska-Wynimko (783014), Sabina Janciauskiene (264288)

مصطلحات موضوعية: Cancer, Cancer Cell Biology, Cancer Diagnosis, Cancer Genetics, Cancer Therapy (excl. Chemotherapy and Radiation Therapy), Chemotherapy, Haematological Tumours, Molecular Targets, Radiation Therapy, Solid Tumours, Oncology and Carcinogenesis not elsewhere classified, NSCLC, checkpoint inhibitors, immunotherapy, acute phase proteins, progression-free survival

Relation: https://figshare.com/articles/dataset/Table_2_Acute_Phase_Proteins_as_Early_Predictors_for_Immunotherapy_Response_in_Advanced_NSCLC_An_Explorative_Study_docx/19094210

الاتاحة: https://doi.org/10.3389/fonc.2022.772076.s005